Insider Transactions in Q4 2024 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,800
-19.73%
|
$2,730,000
$350.0 P/Share
|
|
Oct 28
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+16.96%
|
$991,746
$119.01 P/Share
|
|
Oct 21
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,782
-20.85%
|
$2,848,212
$366.99 P/Share
|
|
Oct 21
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+17.79%
|
$991,746
$119.01 P/Share
|
|
Oct 17
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,864,400
$372.81 P/Share
|
|
Oct 17
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
|
Oct 14
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,792
-22.19%
|
$2,766,160
$355.88 P/Share
|
|
Oct 14
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+18.7%
|
$1,116,756
$134.01 P/Share
|
|
Oct 07
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,794
-23.67%
|
$2,766,870
$355.54 P/Share
|
|
Oct 07
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+19.71%
|
$991,746
$119.01 P/Share
|
|
Oct 03
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,695,000
$350.07 P/Share
|
|
Oct 03
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|